Warby Parker Inc.
Warby Parker Inc. is classed by the SEC under Ophthalmic Goods (industry code 3851), based in New York, NY. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $872 million and a profit of $2 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3851, Ophthalmic Goods); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.9 out of ten, 9 of 9 metrics filed: past 5.6 out of ten, present 5.9 out of ten, future 6.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 6.9 out of ten. No warning events in its filings since 2017. 69th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 6.6 out of ten. +15.3% a year over 7 filed years; profitable in 1 of 7. 66th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 1.9 out of ten. Share count grew 2.9% a year. 0% of cash flow returned. Insiders: 35 sales, 0 purchases. 19th percentile among 5 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 5.3 out of ten. ROE 0%: 0¢ of profit per shareholder dollar. Leverage 49%: owes 49¢ per asset dollar. 53rd percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 5.6 out of ten. top 44% of 8 in its family; net margin 0.2%. 56th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 7.5 out of ten. top 25% of 6 in its family for leadership; chief executive since 2021. 75th percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.8 out of ten. top 42% of 8 in its family for room to expand. 58th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 5.6 out of ten. top 44% of 8 in its family for growth drivers. 56th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 7.3 out of ten. top 27% of 8 in its family for expectations against reality. 73rd percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-26 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-06 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-06 (on EDGAR). Newest filing: Form 4, 2026-10-02. Filings on record since 2010. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Eyewear Products 82%, Contacts Products 11%, Services and Other 6%, Shipping and Handling under 1%. As tagged in its annual report (Form 10-K, filed 2026-02-26).
Who runs it
Blumenthal, Neil Harris (Co-Chief Executive Officer); Gilboa, David Abraham (Co-Chief Executive Officer); Mitchell, Adrian V (Chief Financial Officer); Miller, Steven Clive (Chief Financial Officer); Raider, Jeffrey Jacob (director); Briggs, Teresa (director); Moon, Youngme E (director); Hunt, Andrew (director); Singer, Bradley E (director); Williams, Ronald A (director); and 1 more. 11 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-02.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.